DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Kolb SJ, Coffey CS, Yankey JW. , et al; NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study.
Ann Clin Transl Neurol 2016;
3 (02) 132-145
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.